Influenza, Obesity, Type 2 diabetes research hub

Phase IV open-label clinical trial of the immunogenicity and safety of standard dose trivalent inactivated influenza vaccine (Vaxigrip) in a population of people with obesity

This study is looking at how well the standard flu jab (Vaxigrip) works and how safe it is for people who are obese. It will also look at those with type 2 diabetes. We want to see if their bodies make enough protection against the flu after having the vaccine.